Background Darolutamide is a structurally unique androgen-receptor antagonist that is
under development for the treatment of prostate cancer. We evaluated the efficacy of …

Background In the phase 3 TITAN study, the addition of apalutamide to androgen
deprivation therapy (ADT) significantly improved the primary endpoints of overall survival …

Objectives The objectives of this systematic review were to (a) identify supportive‐care
(psychosocial/behavioral, pharmacological, complementary, or alternative) interventions that …

Abstract Background Quality of Life (QoL) is the most important outcome for patients in
palliative care along with symptom alleviation. Metastatic prostate cancer (mPC) is a life …

Abstract Background The Cancer of the Prostate Risk Assessment (CAPRA) score was
designed and validated several times to predict the biochemical recurrence-free survival …

Primary bone tumors are rare; they account for less than 0.2% of the malignancies
registered. Particularly children and adolescents are affected which make those primary …

This thesis explored the impact of radiotherapy modality and dose escalation for high-risk
prostate cancer patient treatments. This research highlights the potential of combining …

Purpose From the MINDACT trial, Cardoso et al. did not demonstrate a significant efficacy for
adjuvant chemotherapy (CT) for women with early-stage breast cancer presenting high …

METODE: V raziskavo smo vključili bolnike z novougotovljenim razsejanim na kastracijo
odpornim rakom prostate. Za oceno z zdravjem povezane kakovosti življenja smo uporabili …

Résumé L'adaptation des modalités d'irradiation à l'âge peut se discuter du fait d'une
histoire naturelle du cancer de la prostate perçue comme différente, de la prise en compte …